Увійти

Готові списки джерел за темами / Diagnostics of diseases / Статті в журналах

Статті в журналах з теми "Diagnostics of diseases"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Diagnostics of diseases.

Автор: Grafiati

Опубліковано: 30 травня 2022

Оновлено: 31 травня 2022

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Diagnostics of diseases".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Guseynov, Arif. "MODERN DIAGNOSTICS BREAST DISEASES." Clinical Medicine and Pharmacology 6, no. 1 (June 18, 2020): 6–15. http://dx.doi.org/10.12737/2409-3750-2020-6-1-6-15.

Повний текст джерела

Анотація:

The lecture provides information for medical practitioners on the problems of modern diagnosis of breast pathology. The methods of the research, the advantages and disadvantages of each method are described in detail. The questions of differential diagnosis are presented, the optimal schemes and approaches in the diagnosis of the most common diseases of the mammary gland are described.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Kessel, M. "Neglected Diseases, Delinquent Diagnostics." Science Translational Medicine 6, no. 226 (March 5, 2014): 226ed6. http://dx.doi.org/10.1126/scitranslmed.3008194.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Schulz-Knappe, Peter, and Petra Budde. "From Diagnostics to Companion Diagnostics: Targeting Autoimmune Diseases." Clinical OMICs 2, no. 12 (December 2015): 26–28. http://dx.doi.org/10.1089/clinomi.02.12.09.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Kostrova, I. V., and O. B. Prikhodko. "DIFFICULTIES OF DIFFERENTIAL DIAGNOSTICS OF INTERSTITIAL LUNGS DISEASES." Amur Medical Journal, no. 3 (2017): 134–35. http://dx.doi.org/10.22448/amj.2017.3.134-135.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Adamczyk, Jakub, Dominik Sieroń, Karolina Sieroń, Aleksander Sieroń, and Ewa Kucharska. "METHODS OF SPECTRAL DIAGNOSTICS IN MODERN PREVENTION OF ONCOLOGICAL DISEASES." Wiadomości Lekarskie 73, no. 7 (2020): 1313–17. http://dx.doi.org/10.36740/wlek202007101.

Повний текст джерела

Анотація:

This paper contains structured information on photodynamic diagnostics. Photodynamic diagnostics is a young diagnostic modality used in the detection of pre-neoplastic and very early neoplastic lesions. A characteristic feature of the presented method is its completely non-invasive nature and thus the possibility of multiple repetitions at the same patient. This is very important in modern health care and in preventive measures. Aim of the paper: The article aims to present technical and diagnostic possibilities of a photodynamic method as one of the possible modalities of screening diagnostics in patients with ambiguous clinical picture of early neoplastic lesions.

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Tang, Yi-Wei, Gary W. Procop, and David H. Persing. "Molecular diagnostics of infectious diseases." Clinical Chemistry 43, no. 11 (November 1, 1997): 2021–38. http://dx.doi.org/10.1093/clinchem/43.11.2021.

Повний текст джерела

Анотація:

Abstract Over the past several years, the development and application of molecular diagnostic techniques has initiated a revolution in the diagnosis and monitoring of infectious diseases. Microbial phenotypic characteristics, such as protein, bacteriophage, and chromatographic profiles, as well as biotyping and susceptibility testing, are used in most routine laboratories for identification and differentiation. Nucleic acid techniques, such as plasmid profiling, various methods for generating restriction fragment length polymorphisms, and the polymerase chain reaction (PCR), are making increasing inroads into clinical laboratories. PCR-based systems to detect the etiologic agents of disease directly from clinical samples, without the need for culture, have been useful in rapid detection of unculturable or fastidious microorganisms. Additionally, sequence analysis of amplified microbial DNA allows for identification and better characterization of the pathogen. Subspecies variation, identified by various techniques, has been shown to be important in the prognosis of certain diseases. Other important advances include the determination of viral load and the direct detection of genes or gene mutations responsible for drug resistance. Increased use of automation and user-friendly software makes these technologies more widely available. In all, the detection of infectious agents at the nucleic acid level represents a true synthesis of clinical chemistry and clinical microbiology techniques.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Giannobile, William V. "Salivary diagnostics for periodontal diseases." Journal of the American Dental Association 143 (October 2012): 6S—11S. http://dx.doi.org/10.14219/jada.archive.2012.0341.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Dahlén, Gunnar. "Microbiological diagnostics in oral diseases." Acta Odontologica Scandinavica 64, no. 3 (January 2006): 164–68. http://dx.doi.org/10.1080/00016350500520318.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Muldrew, Kenneth L. "Molecular diagnostics of infectious diseases." Current Opinion in Pediatrics 21, no. 1 (February 2009): 102–11. http://dx.doi.org/10.1097/mop.0b013e328320d87e.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Siciliano, Gabriele, Leda Volpi, Selina Piazza, Giulia Ricci, Michelangelo Mancuso, and Luigi Murri. "Functional Diagnostics in Mitochondrial Diseases." Bioscience Reports 27, no. 1-3 (June 13, 2007): 53–67. http://dx.doi.org/10.1007/s10540-007-9037-0.

Повний текст джерела

Анотація:

Mitochondrial diseases (MD) with respiratory chain defects are caused by genetic mutations that determine an impairment of the electron transport chain functioning. Diagnosis often requires a complex approach with measurements of serum lactate, magnetic resonance spectroscopy (MRS), muscle histology and ultrastructure, enzymology, genetic analysis, and exercise testing. The ubiquitous distribution of the mitochondria in the human body explains the multiple organ involvement. Exercise intolerance is a common symptom of MD, due to increased dependence of skeletal muscle on anaerobic metabolism, with an excess lactate generation, phosphocreatine depletion, enhanced free radical production, reduced oxygen extraction and electron flux through the respiratory chain. MD treatment has included antioxidants (vitamin E, alpha lipoic acid), coenzyme Q10, riboflavin, creatine monohydrate, dichloroacetate and exercise training. Exercise is a particularly important tool in diagnosis as well as in the management of these diseases.

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Dunaev, Andrey. "Optical Diagnostics in Human Diseases." Diagnostics 11, no. 5 (May 12, 2021): 873. http://dx.doi.org/10.3390/diagnostics11050873.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Bharadwaj, Mitasha, Michel Bengtson, Mirte Golverdingen, Loulotte Waling, and Cees Dekker. "Diagnosing point-of-care diagnostics for neglected tropical diseases." PLOS Neglected Tropical Diseases 15, no. 6 (June 17, 2021): e0009405. http://dx.doi.org/10.1371/journal.pntd.0009405.

Повний текст джерела

Анотація:

Inadequate and nonintegrated diagnostics are the Achilles’ heel of global efforts to monitor, control, and eradicate neglected tropical diseases (NTDs). While treatment is often available, NTDs are endemic among marginalized populations, due to the unavailability or inadequacy of diagnostic tests that cause empirical misdiagnoses. The need of the hour is early diagnosis at the point-of-care (PoC) of NTD patients. Here, we review the status quo of PoC diagnostic tests and practices for all of the 24 NTDs identified in the World Health Organization’s (WHO) 2021–2030 roadmap, based on their different diagnostic requirements. We discuss the capabilities and shortcomings of current diagnostic tests, identify diagnostic needs, and formulate prerequisites of relevant PoC tests. Next to technical requirements, we stress the importance of availability and awareness programs for establishing PoC tests that fit endemic resource-limited settings. Better understanding of NTD diagnostics will pave the path for setting realistic goals for healthcare in areas with minimal resources, thereby alleviating the global healthcare burden.

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Onischenko, G. G., B. P. Kouzkin, V. V. Kutyrev, S. A. Scherbakova, N. D. Pakskina, and A. V. Toporkov. "Current Trends of Perfection of Laboratory Diagnostics of Particularly Dangerous Infectious Diseases." Problems of Particularly Dangerous Infections, no. 1(99) (February 20, 2009): 5–10. http://dx.doi.org/10.21055/0370-1069-2009-1(99)-5-10.

Повний текст джерела

Анотація:

Considered in the article are current trends of perfection of laboratory diagnostics of particularly dangerous infectious diseases. They are as follows: development and practical introduction of laboratory diagnostics methods based on the modern diagnostic techniques, standardization of the laboratory investigations, accreditation of the laboratories carrying out laboratory diagnostics of particularly dangerous infectious diseases, perfection of the system of external control of the laboratory investigations quality, staff training.

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Wong, DTW. "Salivary Diagnostics." Operative Dentistry 37, no. 6 (October 1, 2012): 562–70. http://dx.doi.org/10.2341/12-143-bl.

Повний текст джерела

Анотація:

SUMMARY Saliva is a noninvasive and accessible biofluid that permits early detection of oral and systemic diseases. Recent scientific and technologic advances have uncovered specific salivary biomarkers for a number of clinical conditions, including cancers, autoimmune diseases, and cardiovascular disorders. The availability of highly sensitive and high-throughput assays such as microarray, mass spectrometry, reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) and nano-scale sensors that can measure proteins and nucleic acids are poising saliva as an emerging biofluid for translational and clinical applications. This paper will discuss development of salivary biomarkers for the detection of oral and systemic diseases and the translational application of these markers for clinical applications.

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Dvořák, Karel. "Noninvasive diagnostics of liver diseases - imaging methods." Vnitřní lékařství 65, no. 9 (September 1, 2019): 539–45. http://dx.doi.org/10.36290/vnl.2019.094.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Sundjaya, Alex Chan. "miRNAs in Autoimmune Diseases: Contributors or Controllers?" Science Insights 40, no. 5 (April 30, 2022): 491–92. http://dx.doi.org/10.15354/si.22.co026.

Повний текст джерела

Анотація:

Even though microRNAs (miRNAs) have been linked to autoimmune diseases, the diagnostic and therapeutic value of miRNAs remains restricted. There is currently no way to determine the function and importance of each miRNA, which makes it impossible to develop targeted medicines and diagnostics for particular diseases. There has been no discovery of a specific miRNA-targeting diagnostic or therapeutic intervention to date.

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Mononen, I. "Laboratory Diagnostics of Lysosomal Storage Diseases." Scandinavian Journal of Clinical and Laboratory Investigation 48 (1988): 81–82. http://dx.doi.org/10.3109/00365518809168517.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Esposito, Susanna. "Infectious Diseases: Pathophysiology, Diagnostics and Prevention." International Journal of Molecular Sciences 17, no. 9 (September 2, 2016): 1464. http://dx.doi.org/10.3390/ijms17091464.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

ARIE, Tsutomu. "Immunology-based Diagnostics for Soilborne Diseases." Journal of Pesticide Science 23, no. 3 (1998): 349–56. http://dx.doi.org/10.1584/jpestics.23.349.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Akopov, A. L., A. S. Agishev, D. V. Dzadzua, A. M. Lazarev, and I. V. Chistyakov. "Surgical diagnostics of interstitial lung diseases." Russian Pulmonology 30, no. 1 (April 21, 2020): 75–80. http://dx.doi.org/10.18093/0869-0189-2020-30-1-75-80.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Jackson, Graham S., Simon Mead, and John Collinge. "Developing early diagnostics for prion diseases." Neurodegenerative Disease Management 3, no. 1 (February 2013): 53–60. http://dx.doi.org/10.2217/nmt.12.76.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Antinoff, Natalie, and Kevin Hahn. "Ferret oncology: diseases, diagnostics, and therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 7, no. 3 (September 2004): 579–625. http://dx.doi.org/10.1016/j.cvex.2004.05.001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Karbelkar, Amruta A., and Ariel L. Furst. "Electrochemical Diagnostics for Bacterial Infectious Diseases." ACS Infectious Diseases 6, no. 7 (June 11, 2020): 1567–71. http://dx.doi.org/10.1021/acsinfecdis.0c00342.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Аюшинова, Natalya Ayushinova, Владимирова, Lyudmila Vladimirova, Ветохина, Antonina Vetokhina, Шурыгин, et al. "MICROBIOLOGICAL DIAGNOSTICS OF PYOINFLAMMATORY ABDOMINAL DISEASES." Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук 1, no. 4 (November 28, 2016): 95–98. http://dx.doi.org/10.12737/22976.

Повний текст джерела

Анотація:

The aim of the work was to establish the significance of complex bacteriological research in the diagnostics of acute appendicitis and to determine an optimal material for the research based on the findings. We examined 19patients with acute phlegmonous or acute gangrenous appendicitis (males, aged 18–60years). We performed bacteriological research of abdominal exudate (n=19) and biopsy specimen (n=19) of appendix wall taken before opening the lumen of the intestine. Both abdominal exudate and appendix wall specimen were taken at the same time. Aerobic and anaerobic microorganisms were detected and identified, antimicrobial susceptibility was tested. In total, we detected 25 strains of aerobic and 13 strains of anaerobic microorganisms. It has been established that a bioptate was most informative for testing (68.4 %); the parallel study of an abdominal exudate gave positive results in 21.1 % of cases. In the structure of clinically significant microflora dominated E.coli (43.3%), then went nonfermentative gram-negative bacteria (13.3%) and Bacteroidesspp. (16.7%). We marked growing resistance of detected strains of gram-negative bacteria to some antibiotics. For instance, 62 % of detected E.c oli strains were resistant to ampicillin, 25 % – to ciprofloxacin. 92 % of strains were resistant to cefepime, 93 % – to ceftriaxone, 77 % – to Amoxiclav, 67 % – to gentamicin, 90 % – to tobramycin. From one bioptate a strain of E. coli ESBL was separated. The study of intraoperative bioptate of appendix wall increases effectiveness of microbiological diagnostics in com-parison with the abdominal exudate research.

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Borisova, O. "IMMUNOLOGICAL DIAGNOSTICS SYSTEMIC CONNECTIVE TISSUE DISEASES." Clinical Medicine and Pharmacology 6, no. 2 (September 3, 2020): 25–39. http://dx.doi.org/10.12737/2409-3750-2020-6-2-25-39.

Повний текст джерела

Анотація:

Modern clinical immunology makes it possible to conduct fairly effective laboratory diagnostics of immuno-inflam-matory rheumatic diseases (IVRS). The applied methods make it possible to obtain objective information about the nature of immunopathological changes, being an important tool for diagnosis, assessment of activity, determining the prognosis, choosing a treatment method for the disease and monitoring the effectiveness of therapy. Currently, the optimal choice and use of immunological methods is possible. The main goal of laboratory diagnostics of IVRS is to obtain objective information about the presence and nature of immunopathological changes in the examined patient, which is an important tool for early diagnosis, assessment of activity, severity of the course, prognosis of the disease and the effectiveness of therapy.

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Kempf, Werner, Michael J. Flaig, and Heinz Kutzner. "Molecular diagnostics in infectious skin diseases." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11, s4 (May 2013): 50–58. http://dx.doi.org/10.1111/ddg.12069_supp.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Kovacs, G. G. "Serum/CSF-diagnostics in neurodegenerative diseases." Journal of the Neurological Sciences 357 (October 2015): e500. http://dx.doi.org/10.1016/j.jns.2015.09.300.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Mononen, I. "Laboratory Diagnostics of Lysosomal Storage Diseases." Scandinavian Journal of Clinical and Laboratory Investigation 48, sup190 (January 1988): 81–82. http://dx.doi.org/10.1080/00365518809168517.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

LIGTENBERG, A. J. M., J. J. DE SOET, E. C. I. VEERMAN, and A. V. N. AMERONGEN. "Oral Diseases: From Detection to Diagnostics." Annals of the New York Academy of Sciences 1098, no. 1 (March 1, 2007): 200–203. http://dx.doi.org/10.1196/annals.1384.040.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

von Kodolitsch, Y., and K. Kutsche. "Genetic diagnostics of inherited aortic diseases." Herz 42, no. 5 (May 29, 2017): 459–67. http://dx.doi.org/10.1007/s00059-017-4577-y.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Fan, Bao Jian, Pancy Oi Sin Tam, Kwong Wai Choy, Dan Yi Wang, Dennis Shun Chiu Lam, and Chi Pui Pang. "Molecular diagnostics of genetic eye diseases." Clinical Biochemistry 39, no. 3 (March 2006): 231–39. http://dx.doi.org/10.1016/j.clinbiochem.2005.11.010.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Düsing, Philip, Andreas Zietzer, and Felix Jansen. "MicroRNA-Based Diagnostics in Heart Diseases." JACC: Basic to Translational Science 6, no. 11 (November 2021): 897–99. http://dx.doi.org/10.1016/j.jacbts.2021.08.004.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Leiferman, Kristin M., Jeremy P. Snook, Mazdak A. Khalighi, Melanie K. Kuechle, and John J. Zone. "Diagnostics for Dermatologic Diseases with Autoantibodies." Journal of Applied Laboratory Medicine 7, no. 1 (January 1, 2022): 165–96. http://dx.doi.org/10.1093/jalm/jfab147.

Повний текст джерела

Анотація:

Abstract Background Dermatologic diseases with autoantibodies were recognized early as autoimmunity became accepted as a pathogenic immunologic concept. Laboratory testing to identify disease-defining autoantibodies and investigate their role in pathophysiology has evolved since. Content Blistering dermatologic diseases, profiled by autoantibody production, target epithelial components critical in cell–cell and cell–matrix adhesion, resulting in epithelial separation and other characteristic features of the disorders. This review covers the clinical indications for dermatologic disease-related autoantibody testing, the specifics of procuring specimens to test, the available diagnostic tests, and information provided by the testing. Atypical, uncharacteristic, and less well-known clinical and autoantibody profiles as well as several of the many future prospects for expansion of the testing applications are elaborated on in the online Data Supplement. Summary Autoantibody-associated dermatologic diseases are acquired immunologic disorders that have considerable clinical implications affecting essential barrier functions of skin and mucous membranes and causing discomfort, including pain and pruritus. Certain of the diseases can have life-threatening manifestations, and treatments can have significant side-effects. The skin diseases may presage other clinical associations that are important to recognize and treat. Laboratory testing aids in the diagnosis of these diseases through identification of the autoantibodies and is essential for prompt and precise knowledge of the disease type for prognosis, further clinical evaluations, and treatment decisions.

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Jovanovic, Milan, Mirjana Milovanovic, Vanja Krstic, and Vojislav Ilic. "General procedures in diagnosis of malignant diseases in dogs and cats." Veterinarski glasnik 66, no. 5-6 (2012): 427–37. http://dx.doi.org/10.2298/vetgl1206427j.

Повний текст джерела

Анотація:

Tumors occur in all domestic and wild animals. They are most often diagnosed in dogs and cats, and their numbers increase from year to year. In the recent years, cancer is believed to be the most frequent cause of pet deaths. A speedy and reliable diagnosis is of paramount importance because it enables the veterinarian to begin therapy and make a prognosis. The objective of an early diagnosis is to enable the detection of neoplastic diseases before the tumor spreads throughout the organism, consequently enabling the timely administration of therapy and providing greater chances for curing the animal. A tumor is diagnosed on the grounds of the anamnesis, clinical picture, and special diagnostic procedures. The most frequently applied diagnostic procedures are laboratory diagnostics, cytology, biopsy and pathohistology, imaging diagnostics (roentgenography and roentgenoscopy, ultrasound diagnostics, endoscopy, computer tomography, magnetic resonance, and scintigraphy) and molecular diagnostics. Each of these methods has its advantages and faults in connection with costs, availability, sensitivity, specificity and quality of anatomic vs functional pictures. Every one of these techniques has its own field of implementation and each one provides different and additional information in connection with the nature and position of the primary lesion and the presence of metastases.

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Lippi, Giuseppe, and Mario Plebani. "Integrated diagnostics." Biochemia medica 30, no. 1 (February 15, 2020): 18–30. http://dx.doi.org/10.11613/bm.2020.010501.

Повний текст джерела

Анотація:

The current scenario of in vitro and in vivo diagnostics can be summarized using the “silo metaphor”, where laboratory medicine, pathology and radiology are three conceptually separated diagnostic disciplines, which will increasingly share many comparable features. The substantial progresses in our understanding of biochemical-biological interplays that characterize many human diseases, coupled with extraordinary technical advances, are now generating important multidisciplinary convergences, leading the way to a new frontier, called integrated diagnostics. This new discipline, which is currently defined as convergence of imaging, pathology and laboratory tests with advanced information technology, has an enormous potential for revolutionizing diagnosis and therapeutic management of human diseases, including those causing the largest number of worldwide deaths (i.e. cardiovascular disease, cancer and infectious diseases). However, some important drawbacks should be overcome, mostly represented by insufficient information technology infrastructures, costs and enormous volume of different information that will be integrated and delivered. To overcome these hurdles, some specific strategies should be defined and implemented, such as planning major integration of exiting information systems or developing innovative ones, combining bioinformatics and imaging informatics, using health technology assessment for assessing cost and benefits, providing interpretative comments in integrated reports, developing and using expert systems and neural networks, overcoming cultural and political boundaries for generating multidisciplinary teams and integrated diagnostic algorithms.

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Holcomb, Zachary E., Ephraim L. Tsalik, Christopher W. Woods, and Micah T. McClain. "Host-Based Peripheral Blood Gene Expression Analysis for Diagnosis of Infectious Diseases." Journal of Clinical Microbiology 55, no. 2 (October 19, 2016): 360–68. http://dx.doi.org/10.1128/jcm.01057-16.

Повний текст джерела

Анотація:

ABSTRACTEmerging pandemic infectious threats, inappropriate antibacterial use contributing to multidrug resistance, and increased morbidity and mortality from diagnostic delays all contribute to a need for improved diagnostics in the field of infectious diseases. Historically, diagnosis of infectious diseases has relied on pathogen detection; however, a novel concept to improve diagnostics in infectious diseases relies instead on the detection of changes in patterns of gene expression in circulating white blood cells in response to infection. Alterations in peripheral blood gene expression in the infected state are robust and reproducible, yielding diagnostic and prognostic information to help facilitate patient treatment decisions.

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Meigal, Alexander Yurievitch, Saara Mirjami Rissanen, Mika P. Tarvainen, Verneri Ruonala, Olavi Airaksinen, Markku Kankaanpää, German G. Miroshnichenko, Anna P. Kuzmina, and Pasi A. Karjalainen. "Novel sEMG parameters for early diagnostics of neurological diseases and aging." Journal of Biomedical Technologies, no. 1 (June 2014): 2–9. http://dx.doi.org/10.15393/j6.art.2014.3041.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Kurbonov, Yokubjon Khamdamovich, Shukhrat Abdujalilovich Boymuradov, and Jamolbek Abdukakharovich Djuraev. "Purulent-Necrotic Diseases Of The Face: Aspects Of Diagnostics And Treatment." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 01 (January 15, 2021): 24–30. http://dx.doi.org/10.37547/tajmspr/volume03issue01-05.

Повний текст джерела

Анотація:

The problem of treatment of pyoinflammatory diseases (PID) of the face and neck is relevant for both dentists of polyclinics and maxillofacial surgeons in hospitals. About 50% of those in maxillofacial hospitals, and about 20% of those who seek help from a dentist and a surgeon of polyclinics, are patients with inflammatory diseases of the maxillofacial region (MFO), among them - 60-80% of patients with abscesses and phlegmons, the frequency of which has increased by 1.5–2.0 times over the past decade. There has been a steady growth of atypical and severely flowing progressive phlegmon, spreading simultaneously in several cellular spaces, with the development of such formidable complications as sepsis, contact mediastinitis, and thrombosis of the cavernous sinus of the dura mater. Low-symptom “erased” forms of phlegmon are found among 13.4–22% of patients, are characterized by a long course and are difficult to diagnose, which contributes to late hospitalization and untimely treatment started. Microbial etiology of HVZ CLO is due to the localization of the primary process (connection with the oral cavity, teeth).

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Volkov, A. N., L. V. Nacheva, and Yu V. Zakharova. "Molecular genetic techniques in current biomedical research. Part II: PCR applications in diagnostics of human infectious diseases." Fundamental and Clinical Medicine 6, no. 1 (March 29, 2021): 77–85. http://dx.doi.org/10.23946/2500-0764-2021-6-1-77-85.

Повний текст джерела

Анотація:

Polymerase chain reaction (PCR)-based diagnostics is currently established as a gold standard for the detection of microorganisms. The features of PCR include rapid amplification of DNA and RNA as well as high sensitivity and specificity. In contrast to diagnostic microbiology, PCR diagnostics does not require preliminary culture of the microorganisms for their identification, reducing both time and costs of the diagnostic procedure. The lecture discusses the molecular basis behind the modern technical solutions for the PCR diagnostics of human infectious diseases including multiplex and reverse transcription PCR. We describe the principles of qualitative and quantitative PCR-based detection of pathogens in biological samples and provide the examples of PCR application for solving specific diagnostic scenarios. The lecture is primarily designed for students of biomedical specialties and healthcare professionals using molecular genetic techniques in their practice.

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Popkov, Vladimir M., Galina N. Maslyakova, and Elena S. Voronina. "Immunohistochemical characteristics in diagnostics of prostate diseases." Russian Open Medical Journal 2, no. 1 (March 25, 2013): 0109. http://dx.doi.org/10.15275/rusomj.2013.0109.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Rapoport, S. I., and Nona A. Shubina. "Respiratory tests in diagnostics of renal diseases." Clinical Medicine (Russian Journal) 94, no. 12 (February 19, 2017): 885–92. http://dx.doi.org/10.18821/0023-2149-2016-94-12-885-892.

Повний текст джерела

Анотація:

C breath tests are the highly efficient noninvasive tools for estimation of liver condition. They provide a basis for the solution of many problems encountered in diagnostics and treatment of hepatic deseases including surgery, chemotherapy and transplantation.

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Vargová, Lenka, and Ladislava Horáčková. "Notes to Palaeopathological Diagnostics of Children’s Diseases." Interdisciplinaria Archaeologica - Natural Sciences in Archaeology I, no. 1-2/2010 (December 31, 2010): 67–73. http://dx.doi.org/10.24916/iansa.2010.1-2.7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Romańczuk, Helena, and Artur Mazur. "Advances in the diagnostics of eye diseases." Medical Review 14, no. 4 (2016): 473–82. http://dx.doi.org/10.15584/medrev.2016.4.10.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Kent, Bethany N. "Sexually Transmitted Diseases: Prevalence, Treatment, and Diagnostics." American Society for Clinical Laboratory Science 30, no. 2 (April 2017): 112–13. http://dx.doi.org/10.29074/ascls.30.2.112.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Scherzer, Clemens R. "Chipping away at diagnostics for neurodegenerative diseases." Neurobiology of Disease 35, no. 2 (August 2009): 148–56. http://dx.doi.org/10.1016/j.nbd.2009.02.016.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Smereczyński, Andrzej, and Katarzyna Kołaczyk. "Ultrasound diagnostics of bowel diseases in adults." Pediatria i Medycyna Rodzinna 11, no. 2 (June 30, 2015): 157–65. http://dx.doi.org/10.15557/pimr.2015.0013.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Mancuso, Michelangelo, Daniele Orsucci, Greta Ali, Annalisa Lo Gerfo, Gabriella Fontanini, and Gabriele Siciliano. "Advances in molecular diagnostics for mitochondrial diseases." Expert Opinion on Medical Diagnostics 3, no. 5 (July 16, 2009): 557–69. http://dx.doi.org/10.1517/17530050902967610.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Merritt, Brian Y. "Molecular Diagnostics of Infectious Diseases, 3rd ed." Laboratory Medicine 46, no. 1 (February 2015): e16-e17. http://dx.doi.org/10.1309/lmt5hfbkcuehrwrf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Syrenicz, Anhelli. "Etiopathogenesis and diagnostics of autoimmune thyroid diseases." Thyroid Research 8, Suppl 1 (2015): A26. http://dx.doi.org/10.1186/1756-6614-8-s1-a26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Blyde, David J. "Respiratory Diseases, Diagnostics, and Treatment of Marsupials." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 497–512. http://dx.doi.org/10.1016/s1094-9194(17)30084-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!